Levels of xCT expression clearly regulate the preference of the usage of glucose and glutamate particularly during tumor cell growth and limitation on nutrient sources41, thus a better understanding on the xCT system in tumor cells may lead to the identification of therapeutic candidate(s) in melanoma. Here, SLC7A11 is linked to neoplasm.